• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Organovo Holdings Inc

+ Add to Watchlist

4OR:GR

5.785 EUR 0.185 3.30%

As of 11:07:38 ET on 07/29/2014.

Snapshot for Organovo Holdings Inc (4OR)

Open: 5.689 Day's Range: 5.520 - 5.800 Volume: 8,640
Previous Close: 5.600 52wk Range: 3.330 - 10.205 1-Yr Rtn: +39.06%

Stock Chart for 4OR

No chart data available.
  • 4OR:GR 5.785
  • 1D
  • 1M
  • 1Y
5.600
Interactive 4OR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4OR

Current P/E Ratio (ttm) -
Estimated P/E(03/2015) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (03/2015) -
Est. PEG Ratio -
Market Cap (M EUR) 452.86
Shares Outstanding (M) 78.28
30 Day Average Volume 4,458
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4OR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 4OR

Organovo Holdings, Inc. is a biology company. The Company focuses on bioprinting technology and creating tissue for research and medical applications.

Keith MurphyChairman/President/CEOBarry D MichaelsCFO/Secretary
Eric Michael DavidChief Strategy Officer/Co-FounderSharon Collins PresnellExec VP:Rsch & Dev/CTO
More Company Profile & Key Executives for 4OR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil